Its the target behind weight loss drugs like Ozempic and Wegovy, and it plays a central role in appetite regulation, blood sugar control, and metabolic health
This February, the US Judicial Panel on Multidistrict Litigation (JPML) c onsolidated similar cases into MDL 3094
10.1038/s41586-019-1705-2 5 BhatM
That dose is for tolerability, not for blood sugar control or weight loss
The drug is currently in Phase 3 trials, with the comprehensive TRIUMPH program evaluating its effects across various patient populations
A potential option for managing PCOS and its effects on weight could be peptides, namely, semaglutide, also widely known as Ozempic and Wegovy